Aitia Expands Collaboration with Servier to Discover and Develop Drugs for Brain Cancer Using AI-Driven Digital Twins
Aitia, a biotech company pioneering the use of causal AI and Digital Twins in drug discovery and development, is expanding its collaboration with Servier, a global and independent pharmaceutical company, to tackle gliomas, a broad group of brain cancers. …